Leta i den här bloggen


måndag 7 oktober 2019

Entä jos hydroxyproliinia (Hyp) kiertää jo valmiina veressä tai soluissa?

https://www.ncbi.nlm.nih.gov/pubmed/2428707

[The value of the free hydroxyproline and the N-acetyl-beta- glucosaminidase for the observation of the course of malignant tumors].

[Article in German]

Abstract

In 172 patients with various malign tumours the free hydroxyprolin (HP) and N-acetyl-beta-glucosaminidase (beta-NAG) in the serum were determined. The established values were analysed according to the kind of tumour, spread of tumour, behaviour of growth and histological classification and statistically evaluated. In mamma carcinoma progressively metastasing into bones HP is significantly increased in its mean value. 71.4 per cent of the patients have pathological values. The parameter for bone-marrow diagnostics failed in 28.6 per cent. Increases may only occur until 9 weeks before traditional diagnostics of metastases. beta-NAG values lie within the normal range for clinically not metastasing mamma carcinoma. The enzyme level will increase significantly after each tumour progression into an organ. The diagnostic sensitivity for the general diagnostics of metastases amounts to 97.7 per cent. Increases without any evidence of metastases are either due to other diseases with connective tissue changes or to occult micrometastases. An exact control is required for these patients. Likewise, HP and beta-NAG have a prognostic importance for malign testicle tumours from nonseminomes character and malign lymphomas, because with tumour progression they will turn into pathological ones. Cytostatics have no direct impact on the serum level of HP and beta-NAG.
PMID:
2428707
[Indexed for MEDLINE]


Kommenttini: Hyp eli hydroxyproliini ei ole essentielli aminohappo, mutta  posttranslationaalisti eräissä struktuureissa tapahtuu Pro-Hyp- muutos, ja se on  rakenteissa essentielliä ( kollageeneissa). Tämä on  vaativa prosessi ja säädelty entsymaattissti.
Se ei pystyne  palautumaan proliiniksi, joka on struktuuriaminohappo.
 Se näitten uusien artikkeleiden mukaan onkin patologisen tilan  biomerkitsijä.  uusimmassa  Nobel palkinnon saaneessa aiheessa ja löydössä on  yksi proteiini, jonka rakenne myös  muuttuu  hydroxyproliineiksi  riippuen  hapen saatavuudesta.  Tässä vielä  atjatelen että  kyse täytyy olla posttranslationaalistasoisesta  modifikaatiosta. Ei kai  villi  happi (ROS )  mitään  hyvää ja järkevää säätelyä tuota.  Täytyy katsoa tarkemmin.

2016;17(6):596-602.

Hydroxyproline: A Potential Biochemical Marker and Its Role in the Pathogenesis of Different Diseases.

1
Department of Pharmacology, Truba Institute of Pharmacy, Bhopal-462038, Madhya Pradesh, India. amitpharmacy21@gmail.com.

Abstract

Hydroxyproline is a non-essential amino acid found in collagen and few other extracellular animal proteins. It's two isomeric forms trans-4-hydroxy-L-proline and trans-3-hydroxy-L-proline play a crucial role in collagen synthesis and thermodynamic stability of the triple-helical conformation of collagen and associated tissues. Various abnormalities in hydroxyproline metabolism have been shown to play key roles in the pathophysiology and pathogenesis of different diseases. The elevated level of hydroxyproline is observed in several disorders, e.g., graft versus host disease, keloids, and vitiligo while its decreased level is a marker of poor wound-healing. This review explores the potential of using hydroxyproline as a biochemical marker to understand the pathogenesis, molecular pathophysiology and treatment of these diseases. The review concludes with an outlook on the scope and challenges in the clinical implementation of hydroxyproline as a biomarker.
PMID:
26916157
[Indexed for MEDLINE]

Inga kommentarer:

Skicka en kommentar